Figs

Figs EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Figs (FIGS) as of Oct 21, 2026 is 36.53. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was 636.20 — a change of -94.26% (lower).

EV/EBITDA

36.53

YoY

-94.26%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Figs is 2025 36.53 . EV/EBITDA (Enterprise Value to EBITDA) of Figs was 2024 636.20 . It decreases by -94.26% lower compared to the previous year.

The Figs EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2019
-4,748.58 USD
Jan 1, 2020
28.10 USD
Jan 1, 2021
147.63 USD
Jan 1, 2022
40.52 USD
Jan 1, 2023
42.28 USD
Jan 1, 2024
636.20 USD
Jan 1, 2025
36.53 USD
The Figs EV/EBITDA history
YEAREV/EBITDAYoY
36.53-94.26%
636.20+1,404.74%
42.28+4.34%
40.52-72.55%
147.63+425.41%
28.10-100.59%
-4,748.58—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Figs Stock analysis

What does Figs do? FIGS, Inc. generates revenue through the direct sale of healthcare apparel and lifestyle products to professionals in 14 countries via its digital platform. The company designs in-house products including scrub wear with functional features like zippered pockets for stethoscopes and ID badges, alongside non-scrub items such as lab coats, loungewear, and compression socks. Its product range also covers under scrubs like performance leggings and Pima cotton tops, as well as accessories including face masks, scrub caps, and tote bags. The firm relies on third-party manufacturers for production while maintaining in-house design control. The primary customer segments are healthcare professionals seeking functional, branded apparel for work and lifestyle needs. FIGS markets its products directly through its digital platform, targeting hospitals, clinics, and individual healthcare workers across 14 countries. The company’s offerings combine practicality with style, emphasizing features like easy-access pockets and comfortable materials such as Pima cotton. This approach supports recurring purchases from healthcare workers who prioritize both professional appearance and personal comfort. FIGS, Inc. differentiates its brand through in-house design and a comprehensive product ecosystem covering scrubs, under scrubs, and lifestyle accessories. The firm’s product portfolio includes lab coats, outerwear, and footwear alongside essentials like face masks and badge reels. By focusing on healthcare-specific apparel needs, FIGS captures a niche market where functionality and brand identity intersect, driving sales through direct digital engagement with its target audience. Figs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Figs stock

EV/EBITDA (Enterprise Value to EBITDA) of Figs is 36.53 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of Figs changed from 636.20 to 36.53, representing a -94.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Figs since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Figs with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Figs

All Key Metrics — Figs